Even healthy, active people can face unexpected diagnoses—sometimes starting with subtle symptoms that are easy to ignore.

The vision of a single blood test that could screen for dozens of different cancers has tantalized oncologists for more than ...

As colorectal cancer rates rise among young people, most patients with advanced disease still only have one treatment option: ...

New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly ...

New findings of an Alliance Foundation Trials study show combining immunotherapy and chemotherapy before surgery improves ...

Nearly half of people diagnosed with advanced cancer over a recent 5-year period did not undergo next-generation sequencing, according to results of a retrospective cohort study.Rates improved over ...

Partial responses in half of patients with platinum-resistant disease, as crowded ADC list ...

Six of eight patients (75%) with HER2-positive rectal adenocarcinoma responded to trastuzumab and tucatinib plus chemotherapy ...

Erdafitinib or Erdafitinib Plus Cetrelimab for Patients With Metastatic Urothelial Carcinoma and FGFR Alterations: Final Results From the Phase II NORSE Study This multicenter open-label RCT enrolled ...

Read full article: Virginia Tech sophomore starts foundation to assist Carilion Clinic’s new Cancer Center Read full article: Vinton Dogwood Festival returns for 71st year One person is dead and four ...

NGS utilization increased over time but left substantial proportions untested across metastatic breast, prostate, pancreatic, ...

Patients with advanced cancer were twice as likely to report receiving life-extending care despite an expressed preference for comfort-focused care. Discordant care did not improve 24-month survival ...